Comparative trials of peginterferon α2a and peginterferon α2b for chronic hepatitis C

Maria Grazia Rumi(University of Milan), G.M. Prati(University of Milan), Alessio Aghemo
Journal of Viral Hepatitis
January 1, 2012
10.1111/j.1365-2893.2011.01525.x
Cited by 7

Related Papers

Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|˜The œLancet. Gastroenterology & hepatology|2022|664
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
|Journal of Clinical Investigation|1996|661
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|˜The œLancet. Gastroenterology & hepatology|2019|539
The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis
|Gut|2009|406
A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
|Hepatology|2012|405